Literature DB >> 23417061

Percutaneous vertebroplasty for osteoporotic vertebral compression fracture with intravertebral cleft associated with delayed neurologic deficit.

Toshio Nakamae1, Yoshinori Fujimoto, Kiyotaka Yamada, Haruhiko Takata, Takuro Shimbo, Yasuyuki Tsuchida.   

Abstract

INTRODUCTION: The number of cases of osteoporotic vertebral compression fracture (OVCF) with intravertebral cleft (IVC) with delayed neurologic deficit (DND) is increasing as the population ages. However, the cause of DND is poorly understood, and no definitive treatment of the disease has been established. The purpose of this study was to clarify the radiographic parameters contributing to the occurrence of DND, and to evaluate the efficacy and safety of percutaneous vertebroplasty for this pathology.
METHODS: Percutaneous vertebroplasty was prospectively performed for 244 patients with OVCF with IVC; 30 had DND and 214 did not. Radiographic parameters of local kyphotic angle, percent spinal canal compromise and intravertebral instability were investigated for correlations to DND. Procedural outcomes were evaluated using visual analog scale (VAS), Oswestry Disability Index (ODI), and modified Frankel grades.
RESULTS: Before vertebroplasty, no substantial difference in local kyphotic angle was seen between OVCF with IVC with and without DND, but percent spinal canal compromise and intravertebral instability were greater in OVCF with IVC with DND (P < 0.001). After vertebroplasty, 25 of 30 cases (84%) of OVCF with IVC with DND achieved clinically meaningful improvement (CMI), but 5 (17%) did not. Patients with CMI showed substantial improvements in intravertebral instability (P < 0.001), and no change in local kyphotic angle or percent spinal canal compromise. In five patients without CMI, four showed an initial improvement, but subsequent vertebral fracture adjacent to the treated vertebra caused neurologic re-deterioration. One patient with percent spinal canal compromise 54.9% and intravertebral instability 4° achieved no neurologic improvement following vertebroplasty. No serious complications or adverse events related to the procedure were encountered.
CONCLUSIONS: Intravertebral instability is the dominant cause of DND. Percutaneous vertebroplasty appears effective and safe in the treatment of OVCF with IVC with DND. Patients with less intravertebral instability and severe spinal canal compromise could be candidates for conventional surgical treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23417061      PMCID: PMC3698354          DOI: 10.1007/s00586-013-2686-8

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  36 in total

1.  Vertebroplasty-augmented short-segment posterior fixation of osteoporotic vertebral collapse with neurological deficit in the thoracolumbar spine: comparisons with posterior surgery without vertebroplasty and anterior surgery.

Authors:  Kenzo Uchida; Hideaki Nakajima; Takafumi Yayama; Tsuyoshi Miyazaki; Takayuki Hirai; Shigeru Kobayashi; Kebing Chen; Alexander Rodriguez Guerrero; Hisatoshi Baba
Journal:  J Neurosurg Spine       Date:  2010-11

2.  Percutaneous vertebroplasty in vertebral osteonecrosis (Kummell's spondylitis).

Authors:  H M Do; M E Jensen; W F Marx; D F Kallmes
Journal:  Neurosurg Focus       Date:  1999-07-15       Impact factor: 4.047

3.  Epidemiology of vertebral fractures in women.

Authors:  L J Melton; S H Kan; M A Frye; H W Wahner; W M O'Fallon; B L Riggs
Journal:  Am J Epidemiol       Date:  1989-05       Impact factor: 4.897

Review 4.  Pathophysiology and natural history of avascular necrosis of bone.

Authors:  Pierre Lafforgue
Journal:  Joint Bone Spine       Date:  2006-08-08       Impact factor: 4.929

5.  Open vertebral cement augmentation combined with lumbar decompression for the operative management of thoracolumbar stenosis secondary to osteoporotic burst fractures.

Authors:  Kern Singh; John G Heller; Dino Samartzis; J Scott Price; Howard S An; S Tim Yoon; John Rhee; Jon T Ledlie; Frank M Phillips
Journal:  J Spinal Disord Tech       Date:  2005-10

6.  Posterior spinal shortening for paraplegia after vertebral collapse caused by osteoporosis.

Authors:  K Saita; Y Hoshino; I Kikkawa; H Nakamura
Journal:  Spine (Phila Pa 1976)       Date:  2000-11-01       Impact factor: 3.468

7.  The treatment of osteoporotic-posttraumatic vertebral collapse using the Kaneda device and a bioactive ceramic vertebral prosthesis.

Authors:  K Kaneda; S Asano; T Hashimoto; S Satoh; M Fujiya
Journal:  Spine (Phila Pa 1976)       Date:  1992-08       Impact factor: 3.468

8.  Osteoporosis with vertebral compression fractures, retropulsed fragments, and neurologic compromise.

Authors:  P A Kaplan; D F Orton; R J Asleson
Journal:  Radiology       Date:  1987-11       Impact factor: 11.105

9.  Thigh pain and multiple vertebral osteonecroses: value of magnetic resonance imaging.

Authors:  X Chevalier; N Wrona; B Avouac; B Larget-Piet
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

10.  Vertebral pseudarthrosis in the osteoporotic spine.

Authors:  K Hasegawa; T Homma; S Uchiyama; H Takahashi
Journal:  Spine (Phila Pa 1976)       Date:  1998-10-15       Impact factor: 3.468

View more
  15 in total

Review 1.  The Michel Benoist and Robert Mulholland Yearly European Spine Journal Review: a survey of the "medical" articles in the European Spine Journal, 2013.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2013-12-13       Impact factor: 3.134

2.  Therapeutic effects of PKP on chronic painful osteoporotic vertebral compression fractures with or without intravertebral cleft.

Authors:  Debo Zou; Kaining Zhang; Yanjun Ren
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Intervertebral bridging ossifications increase the risk of intravertebral cleft formation following a vertebral compression fracture.

Authors:  Atsushi Kimura; Teruaki Endo; Hirokazu Inoue; Katsushi Takeshita
Journal:  Eur Spine J       Date:  2015-06-13       Impact factor: 3.134

4.  Evolution of vertebral posttraumatic necrosis to bone healing after self-stabilizing osteophytosis development-case report.

Authors:  Diogo Filipe Lino Moura; Josué Pereira Gabriel
Journal:  J Spine Surg       Date:  2021-12

5.  Efficacy analysis of percutaneous pedicle screw fixation combined with percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures with kyphosis.

Authors:  Zhikun Li; Yi Wang; Youjia Xu; Wei Xu; Xiaodong Zhu; Chao Chen
Journal:  J Orthop Surg Res       Date:  2020-02-17       Impact factor: 2.359

6.  The therapeutic effects of percutaneous kyphoplasty on osteoporotic vertebral compression fractures with or without intravertebral cleft.

Authors:  Zhe Li; Tie Liu; Peng Yin; Yu Wang; Shengen Liao; Shuo Zhang; Qingjun Su; Yong Hai
Journal:  Int Orthop       Date:  2018-07-16       Impact factor: 3.075

Review 7.  Posttraumatic Delayed Vertebral Collapse : Kummell's Disease.

Authors:  Jeongwook Lim; Seung-Won Choi; Jin-Young Youm; Hyon-Jo Kwon; Seon-Hwan Kim; Hyeon-Song Koh
Journal:  J Korean Neurosurg Soc       Date:  2017-12-29

8.  Risk Factors for Cement Loosening after Vertebroplasty for Osteoporotic Vertebral Fracture with Intravertebral Cleft: A Retrospective Analysis.

Authors:  Toshio Nakamae; Kiyotaka Yamada; Yasuyuki Tsuchida; Orso Lorenzo Osti; Nobuo Adachi; Yoshinori Fujimoto
Journal:  Asian Spine J       Date:  2018-09-10

9.  Indication for Partial Vertebral Osteotomy and Realignment in Posterior Spinal Fixation for Osteoporotic Thoracolumbar Vertebral Collapse with Neurological Deficits.

Authors:  Toshiyuki Takahashi; Junya Hanakita; Taigo Kawaoka; Yasufumi Ohtake; Hiromasa Adachi; Kampei Shimizu
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-03-28       Impact factor: 1.742

10.  Response to: Risk Factors for Cement Loosening after Vertebroplasty for Osteoporotic Vertebral Fracture with Intravertebral Cleft: A Retrospective Analysis.

Authors:  Toshio Nakamae; Kiyotaka Yamada; Yasuyuki Tsuchida; Orso Lorenzo Osti; Nobuo Adachi; Yoshinori Fujimoto
Journal:  Asian Spine J       Date:  2019-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.